MedTrace Logo

Efficacy Study of Diazoxide Choline to Treat Hypertriglyceridemia

NCT01211847 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2014-01-10

No results posted yet for this study

Summary

Once a day oral administration with DCCR helps lower triglycerides

Conditions

Interventions

DRUG

Diazoxide Choline Controlled-Release Tablet

DCCR 290 mg once a day for 126 days

DRUG

Placebo

Placebo matching DCCR

Sponsors & Collaborators

  • Medpace, Inc.

    collaborator INDUSTRY

  • Essentialis, Inc.

    lead INDUSTRY

Principal Investigators

  • Alain Baron, M.D. · Essentialis, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2011-09-30
Completion
2011-12-31

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01211847 on ClinicalTrials.gov